Approach

Developing translational research

BioQuanta has always understood that the best answers come from the best technology. In the areas where sufficient technology was not available, we have developed new tools ourselves.

The translational research approach allows us to directly identify specific biomarkers from the clinical setting and correlate them with pathologies.

• Our partnerships with hospitals allows us to work with clinicians to identify unmet needs in biomarkers and dosage kits.
• Our technical and analytical expertise allows us to define the most appropriate method for administering these biomarkers.
• Our expertise in clinical biology allows us to develop diagnostic kits based on these markers that will be easy to use for biologists and industry chemists.
• Our expertise in molecular modeling allows us to design reagents necessary for the kits.
• We can guarantee the technical validation of dosage regimens on standard laboratory machines.
• We can guarantee the clinical relevance of our biomarkers through our partnership with the doctors who administer these dosages.

New biomarkers and the diagnostic kits based on them respond to strong unmet demands of clinicians. These markers and kits have broad applicability, from clinical biology (diagnostics), to life sciences (R&D),  to industrial chemistry (quality control).

 

We keep our solutions at the cutting edge through continuous development with our clinical partnerships.